Mainz Biomed NV (MYNZ)
(Delayed Data from NSDQ)
$0.36 USD
+0.01 (3.40%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $0.36 0.00 (0.28%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Income Statements
Fiscal Year end for Mainz Biomed NV falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 1 | 1 | 0 | NA |
Cost Of Goods | 0 | 0 | 0 | 0 | NA |
Gross Profit | 1 | 0 | 0 | 0 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 27 | 27 | 10 | 1 | 0 |
Income After Depreciation & Amortization | -27 | -27 | -10 | -1 | 0 |
Non-Operating Income | 1 | 0 | -2 | 0 | NA |
Interest Expense | 0 | 0 | 0 | 0 | NA |
Pretax Income | -26 | -26 | -12 | -1 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -26 | -26 | -12 | -1 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -26 | -26 | -12 | -1 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -26 | -26 | -10 | -1 | 0 |
Depreciation & Amortization (Cash Flow) | 1 | 0 | 0 | 0 | NA |
Income After Depreciation & Amortization | -27 | -27 | -10 | -1 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 16.24 | 14.16 | 7.21 | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.62 | -1.86 | -1.62 | NA | NA |
Diluted Net EPS (GAAP) | -1.62 | -1.86 | -1.62 | NA | NA |
Fiscal Year end for Mainz Biomed NV falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | 0.21 | 0.18 | 0.25 |
Cost Of Goods | NA | NA | 0.08 | 0.09 | 0.10 |
Gross Profit | NA | NA | 0.13 | 0.09 | 0.15 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 6.72 | 5.72 | 8.08 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | -6.59 | -5.63 | -7.93 |
Non-Operating Income | NA | NA | 1.66 | -0.66 | -0.33 |
Interest Expense | NA | NA | 0.25 | 0.00 | 0.00 |
Pretax Income | NA | NA | -5.18 | -6.30 | -8.25 |
Income Taxes | NA | NA | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | NA | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | NA | -5.18 | -6.30 | -8.25 |
Extras & Discontinued Operations | NA | NA | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | -5.18 | -6.30 | -8.25 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 16.24 | 15.97 | 14.92 |
Diluted EPS Before Non-Recurring Items | NA | NA | -0.24 | -0.39 | -0.56 |
Diluted Net EPS (GAAP) | NA | NA | -0.22 | -0.39 | -0.56 |